Respiratory viral infections are increasingly recognized for their potential to lead to acute cardiovascular decompensations and systemic cardiovascular sequelae.
The intersection between infectious diseases and cardiovascular outcomes has never been more pressing than in the post-COVID-19 pandemic era.Respiratory viral infections (RVIs)including influenza, SARS-CoV-2, and respiratory syncytial virus (RSV)-are increasingly recognized for their acute respiratory manifestations potentially leading to acute cardiovascular (CV) decompensations and systemic, particularly CV, sequelae.In their recent contribution to the European Journal of Preventive Cardiology, Wee et al. present compelling data quantifying the
Loubet et al. (Thu,) conducted a editorial in Respiratory viral infections and cardiovascular outcomes. Respiratory viral infections (RVIs) was evaluated. Respiratory viral infections are increasingly recognized for their potential to lead to acute cardiovascular decompensations and systemic cardiovascular sequelae.